These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29643001)

  • 1. Immune-cell BDNF expression in treatment-naïve relapsing-remitting multiple sclerosis patients and following one year of immunomodulation therapy.
    Kalinowska-Łyszczarz A; Pawlak MA; Wyciszkiewicz A; Osztynowicz K; Kozubski W; Michalak S
    Neurol Neurochir Pol; 2018 Aug; 52(4):483-489. PubMed ID: 29643001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Clin Immunol; 2006 Jan; 118(1):77-82. PubMed ID: 16275091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Cell Neurotrophin Production Is Associated with Subcortical Brain Atrophy in Neuropsychiatric Systemic Lupus Erythematosus Patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Wyciszkiewicz A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Paprzycki W; Kozubski W; Michalak S
    Neuroimmunomodulation; 2017; 24(6):320-330. PubMed ID: 29539621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients.
    Patanella AK; Zinno M; Quaranta D; Nociti V; Frisullo G; Gainotti G; Tonali PA; Batocchi AP; Marra C
    J Neurosci Res; 2010 Apr; 88(5):1106-12. PubMed ID: 19885866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
    Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
    [No Abstract]   [Full Text] [Related]  

  • 6. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
    J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Gioia MC; Valentino P; Manna I; Condino F; Cerasa A; La Russa A; Clodomiro A; Paolillo A; Nisticò R; Vercillo L; Cittadella R; Quattrone A
    Genes Brain Behav; 2007 Mar; 6(2):177-83. PubMed ID: 16740142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis.
    Liguori M; Fera F; Patitucci A; Manna I; Condino F; Valentino P; Telarico P; Cerasa A; Gioia MC; di Palma G; Quattrone A
    Brain Res; 2009 Feb; 1256():123-8. PubMed ID: 19071096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Scand J Immunol; 2005 Aug; 62(2):176-82. PubMed ID: 16101825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins.
    Sarchielli P; Zaffaroni M; Floridi A; Greco L; Candeliere A; Mattioni A; Tenaglia S; Di Filippo M; Calabresi P
    Mult Scler; 2007 Apr; 13(3):313-31. PubMed ID: 17439900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of IFN-β Treatment on Plasma Levels of BDNF and IL-6 in Relapsing-Remitting Multiple Sclerosis Patients.
    Shajarian M; Alsahebfosoul F; Etemadifar M
    Neuroimmunomodulation; 2021; 28(3):150-157. PubMed ID: 34182566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients.
    Kalinowska-Łyszczarz A; Pawlak MA; Michalak S; Paprzycki W; Losy J
    J Neuroimmunol; 2011 Dec; 240-241():109-13. PubMed ID: 22036954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
    Waschbisch A; Atiya M; Linker RA; Potapov S; Schwab S; Derfuss T
    PLoS One; 2011; 6(9):e24604. PubMed ID: 21949733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: reversal by glatiramer acetate.
    Azoulay D; Vachapova V; Shihman B; Miler A; Karni A
    J Neuroimmunol; 2005 Oct; 167(1-2):215-8. PubMed ID: 16083971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.
    Lalive PH; Kantengwa S; Benkhoucha M; Juillard C; Chofflon M
    J Neuroimmunol; 2008 Jul; 197(2):147-51. PubMed ID: 18555540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients.
    Gielen A; Khademi M; Muhallab S; Olsson T; Piehl F
    Scand J Immunol; 2003 May; 57(5):493-7. PubMed ID: 12753507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of the RUNXOR/RUNX1 axis in multiple sclerosis.
    Haridy SFA; Shahin NN; Shabayek MI; Selim MM; Abdelhafez MA; Motawi TK
    Neurobiol Dis; 2023 Mar; 178():106032. PubMed ID: 36754216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor.
    Ziemssen T; Kümpfel T; Klinkert WE; Neuhaus O; Hohlfeld R
    Brain; 2002 Nov; 125(Pt 11):2381-91. PubMed ID: 12390966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
    Tongiorgi E; Sartori A; Baj G; Bratina A; Di Cola F; Zorzon M; Pizzolato G
    J Neurol Sci; 2012 Sep; 320(1-2):161-5. PubMed ID: 22836016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.